More Food & Drug Administration (FDA) Articles

Food & Drug Administration (FDA)

Vaccines: Where are We?

As the U.S. marches on with the two approved COVID-19 vaccines, it seems that the original plan to vaccinate 20 million people by the end of 2020 fell a little short. McNees Wallace & Nurick associate, Langdon Ramsburg, assesses where the situation stands and what comes next.

Read More

Cannabis

Navigating the Cannabis Industry Gray Zone

Legal advice surrounding the regulatory status of cannabis and hemp-based products is a moving target, but Howard Sklamberg keeps his clients apace.

Read More

Healthcare

Steady Hands to Navigate the FDA's Balance of Innovation and Safety

Nathan Brown and Howard Sklamberg bring their experience at the Food and Drug Administration to bear when counseling Akin Gump clients on pre- and post-market compliance issues and more.

Read More